title: Lyme disease in Belgium.
abstract: A sero-epidemiological clinical and risk-group study was performed in Belgian Military men with a home-made Elisa kit, with the N34 Bb strain kindly provided by Prof. Ackermann Cologne. In the sero-epidemiological group the seroprevalence (age 18-28 years) was 3.2% In the clinical group the results were correlating to the serological and clinical data. In the risk group 44% were IgG positive. In conclusion the exposure of a standard Belgian young male population is low. (Overall IgG seropositivity 3.2%) (Total N = 1,916).
authors.affiliation: Belgian Military Hospitals, Brussels.
authors.forename: J
authors.initials: J
authors.lastname: Clement
authors.forename: R
authors.initials: R
authors.lastname: Wouters
authors.forename: A
authors.initials: A
authors.lastname: Lefevre
authors.forename: M
authors.initials: M
authors.lastname: Hertens
authors.forename: A
authors.initials: A
authors.lastname: Ramon
authors.forename: R
authors.initials: R
authors.lastname: Ackermann
mesh_terms: D000293:Adolescent; D000328:Adult; D001530:Belgium / Q000453:epidemiology; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D008193:Lyme Disease / Q000453:epidemiology*; D008297:Male; D008889:Military Personnel; D012307:Risk Factors; D016036:Seroepidemiologic Studies